Tech Gains 12 as Markets Flat SP 500 NASDAQ Dow Unchanged FPT Wins Three Awards at 2026 Globee Awards for Artificial Intelligence Strengthening AI Innovation Credentials US National Debt Surpasses Economy A Cause for Concern DraftKings Faces Scaling Challenges as Morgan Stanley Revises Price Target RBIs USDINR Swap Auction Sees Robust Bidding at Double the Notified 5 Billion Amount Buffetts Tiny Purchase Hinted at in March Berkshire Filing Suggests Small New Position Googles New Smart Glasses Set for Autumn Launch Marks PostGoogle Glass Era Lessons from Ebola Crisis Management Implications for Healthcare Investment and Preparedness Mamaearth and LIC Lead Fridays Stock Movers Among Top Gainers and Losers Plus500 Reports 11 Quarterly Revenue Growth Says FullYear Outlook on Track Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues WMB Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Edges Higher SNCY Q1 2026 Earnings EPS Miss Weighs on Market Sentiment as Revenue Figures Remain Undisclosed VLTO Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance NCLH Q1 2026 Earnings Strong EPS Beat of 58 Surprises Analysts Yet Stock Declines PM Q1 2026 Earnings Earnings Beat Expectations Amid Solid Pricing Power Braiin Limited BRAI Skyrockets Over 96 Key Levels to Watch Teledyne Technologies TDY Rebounds 22 as It Challenges Key Resistance Harmony Biosciences HRMY Holds Steady After Modest Gain Support and Resistance in Focus Definium Therapeutics DFTX Surges 341 as Volume Picks Up Testing Key Resistance ACV Auctions ACVA Inches Higher as Buyers Test Key Resistance Zone Toshifumi Suzuki Architect of 7Elevens Global Empire Dies at 93 NFE Q1 2026 Earnings EPS Misses Estimates as Losses Widen Phoenix Education Partners Inc PXED Narrow Price Movement Suggests Consolidation Near Support CNM Q1 2026 Earnings EPS Surpasses Estimates by Nearly 23 Fueled by Strong Demand in Water Infrastructure ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress ICON Q4 2025 Earnings EPS Misses Estimates Amidst Operational Challenges Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline TCBI Q1 2026 Earnings EPS Surpasses Expectations by 898 as Shares Edge Lower WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility NBP Q4 2025 Earnings Significant EPS Miss Yet Stock Surges 763